# EDGAR Filing Document

**Accession Number:** 0001899017
**File Stem:** 0001193125-26-142482
**Filing Date:** 2026-4
**Character Count:** 11853
**Document Hash:** 8a36cd73ff02f7fcc28d259b202cbe19
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-142482.hdr.sgml**: 20260403

**ACCESSION NUMBER**: 0001193125-26-142482

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D/A

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20260403

**DATE AS OF CHANGE**: 20260403

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bain Capital Private Credit
- **CENTRAL INDEX KEY:** 0001899017

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94247
- **FILM NUMBER:** 26839271

**BUSINESS ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 617.516.2000

**MAIL ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Bain Capital DCB Investments, LP
- **CENTRAL INDEX KEY:** 0002055128

**ORGANIZATION NAME:**
- **EIN:** 881978410
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D/A

**BUSINESS ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116
- **BUSINESS PHONE:** 6175162000

**MAIL ADDRESS:**
- **STREET 1:** 200 CLARENDON STREET
- **CITY:** BOSTON
- **STATE:** MA
- **ZIP:** 02116

## Exhibit 99.2

**JOINT FILING AGREEMENT** 

The undersigned hereby agree that the foregoing statement on Schedule 13D is filed on behalf of each of the undersigned, and any amendments thereto executed by the undersigned shall be filed on behalf of each of the undersigned without the necessity of filing any additional joint filing agreement. The undersigned acknowledge that each is responsible for the timely filing of such statement on Schedule 13D and any amendments thereto, and for the completeness and accuracy of the information concerning him or it contained therein, but shall not be responsible for the completeness or accuracy of the information concerning the others of the undersigned, except to the extent that he or it knows or has reason to believe that such information is inaccurate or incomplete. This Joint Filing Agreement may be executed in any number of counterparts, all of which taken together shall constitute one and the same instrument.

Dated: April 3, 2026

---

| |
|:---|
| &nbsp;&nbsp;Bain Capital DCB Investments, LP<br>|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Kase Jubboori</u> <br>Name: Kase Jubboori <br>Title: Authorized Signatory |
| &nbsp;&nbsp;Bain Capital DCB Investments II, LP<br>|
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;By: <u>/s/ Kase Jubboori</u> <br>Name: Kase Jubboori<br>Title: Authorized Signatory  |

---

------

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**(Amendment No. 8)**

**Bain Capital Private Credit**

*(Name of Issuer)*

**Common Shares of Beneficial Interest, $0.01 par value per share ("Common Shares")**

*(Title of Class of Securities)*

**—**

*(CUSIP Number)*

**Bain Capital DCB Investments**<br>200 Clarendon Street<br>Boston MA 02116<br>617-516-2000

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**04/01/2026**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bain Capital DCB Investments, LP** | Name of reporting person<br>**Bain Capital DCB Investments, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**3988207.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**3988207.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**0.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**3988207.00** | Aggregate amount beneficially owned by each reporting person<br>**3988207.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**10.2%** | Percent of class represented by amount in Row (11)<br>**10.2%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

| **CUSIP No.** | **—** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Bain Capital DCB Investments II, LP** | Name of reporting person<br>**Bain Capital DCB Investments II, LP** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**WC** | Source of funds (See Instructions)<br>**WC** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**DELAWARE** | Citizenship or place of organization<br>**DELAWARE** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**1159303.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**1159303.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**1159303.00** | Aggregate amount beneficially owned by each reporting person<br>**1159303.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**2.9%** | Percent of class represented by amount in Row (11)<br>**2.9%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**PN** | Type of Reporting Person (See Instructions)<br>**PN** | |

---

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Shares of Beneficial Interest, $0.01 par value per share ("Common Shares")

**(b) Name of Issuer:**
Bain Capital Private Credit

**(c) Address of Issuer's Principal Executive Offices:**
200 Clarendon Street, Boston, MA, 02116

This Amendment No. 8 ("Amendment No. 8") to Schedule 13D amends and supplements the statement on Schedule 13D originally filed on February 2, 2025, as amended by Amendment No. 1 to Schedule 13D  filed on March 4, 2025, Amendment No. 2 to Schedule 13D filed on March 19, 2025, Amendment No. 3 to Schedule 13D filed on April 3, 2025, Amendment No. 4 to Schedule 13D filed on May 5, 2025, Amendment No. 5 to Schedule 13D filed on September 3, 2025, Amendment No. 6 to Schedule 13D filed on November 4, 2025 and Amendment No. 7 to Schedule 13D filed on February 4, 2026 (together, the "Original Schedule 13D"), with respect to the Common Shares of the Issuer. The Reporting Persons are filing this amendment to add Bain Capital DCB Investments II, LP ("DCB II") as a Reporting Person and report its acquisition of Common Shares. Capitalized terms used but not defined herein have the meanings ascribed to such terms in the Original Schedule 13D.

**Item 4. Purpose of Transaction**

The information set forth in Items 3 and 6 of this Statement are incorporated by reference in its entirety into this Item 4.

The Reporting Persons acquired the securities reported herein for investment purposes. The Reporting Persons are affiliates of BCPC Advisors, LP, the Issuer's investment advisor (the "Advisor"). From time to time, in such capacity and as a significant shareholder of the Issuer, the Reporting Persons may engage in discussions with the Advisor and officers and trustees of the Issuer regarding the management of the Issuer. Each Reporting Person reviews and intends to continue to review its investment in the Issuer. Depending upon the factors discussed below and subject to applicable law, a Reporting Person may from time to time acquire additional securities of the Issuer or sell or otherwise dispose of some or all of its securities of the Issuer. A Reporting Person may pursue any such transactions at any time and from time to time without prior notice, and such transactions will depend upon a variety of factors, including current and anticipated future trading prices of the securities of the Issuer, the financial condition, results of operations and prospects of the Issuer, general economic, financial market and industry conditions, other investment and business opportunities available to such Reporting Person, tax considerations and other factors

**Item 5. Interest in Securities of the Issuer**

**(a)**
As of the date herof, DCB holds 3,998,207.55 Common Shares, representing approximately 10.2% of the outstanding Common Shares.

As of the date herof, DCB II may be deemed to beneficially own 1,159,303.80 Common Shares, representing approximately 2.9% of the outstanding Common Shares. The information included in Item 3 is incorporated by reference herein.

**(b)**
Based on information receieved by the Reporting Person from the Issuer, there are 39,305,782.62 Common Shares outstanding as of April 1, 2026. The information included in Item 3 is incorporated by reference herein.

**(c)**
Execept as reported in the Statement, none of the Reporting Persons, DCB GP nor any of the indivuduals listed on Schedule I has effected any transactions in the Common Shares during the past sixty (60) days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

The information set forth in Items 3 and 4 of this Statement is incorporated by reference in its entirety into this Item 6.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bain Capital DCB Investments, LP

**Signature:** /s/ Kase Jubboori

**Name/Title:** Kase Jubboori, Authorized Signatory

**Date:** 04/03/2026

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Bain Capital DCB Investments II, LP

**Signature:** /s/ Kase Jubboori

**Name/Title:** Kase Jubboori, Authorized Signatory

**Date:** 04/03/2026